| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL PAPER |
a First Department of Pathology,
b Pediatrics, Kansai Medical University, Osaka, Japan;
c Department of Molecular Biology, Cancer Institute, Tokyo, Japan
Key Words. Hemopoietic stem cells • c-kit • CD34 • IL-6R • Sca-1
Correspondence: Dr. Susumu Ikehara, First Department of Pathology, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570, Japan.
Cytokines play a crucial role in the differentiation and proliferation of hemopoietic cells, and it has recently been found that adhesion molecules play crucial roles not only in differentiation and proliferation, but also in the homing and other functions of hemopoietic cells. We have very recently established a new method for purifying pluripotent hemopoietic stem cells (P-HSC) in mice by injecting 5-fluorouracil (5-FU). The P-HSC were found to be low-density, lineage marker-negative (Lin–), CD71– and major histocompatibility complex class Ihigh. In the present study, we analyze changes in the expression of various HSC markers (Sca-1 and CD34), receptors (c-kit and interleukin-6 receptor [IL-6R]) and adhesion molecules (very late activation antigen-4 [VLA-4], lymphocyte function-associated antigen-1 [LFA-1], and CD44) after 5-FU injection. The percentage of Sca-1+ cells increases after 5-FU treatment, reaching a maximum on day 3, whereas the percentage of IL-6R+ cells decreases, reaching a minimum on day 3. The percentage of CD34+ cells does not change after 5-FU treatment. The percentages of both c-kitlow and c-kithigh cells decrease, reaching a minimum on day 3 after 5-FU treatment, whereas the percentage of c-kit– cells reciprocally increases, reaching a maximum on day 3. However, there is no change in the expression of adhesion molecules (VLA-4, LFA-1 and CD44) on the P-HSC.
This article has been cited by other articles:
|
|
 |
|
  R. Pelayo, K. Miyazaki, J. Huang, K. P. Garrett, D. G. Osmond, and P. W. Kincade Cell Cycle Quiescence of Early Lymphoid Progenitors in Adult Bone Marrow Stem Cells, December 1, 2006; 24(12): 2703 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Campard, M. Vasse, S. Rose-John, F. Poyer, M. Lamacz, and J.-P. Vannier Multilevel Regulation of IL-6R by IL-6-sIL-6R Fusion Protein According to the Primitiveness of Peripheral Blood-Derived CD133+ Cells Stem Cells, May 1, 2006; 24(5): 1302 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Murante and T. A. Gasiewicz Hemopoietic Progenitor Cells Are Sensitive Targets of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in C57BL/6J Mice Toxicol. Sci., April 1, 2000; 54(2): 374 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Poujol, D. T.-L. Roux, P. Tropel, V. Roullot, A. Nurden, G. Marguerie, and P. Nurden Ultrastructural Analysis of Bone Marrow Hematopoiesis in Mice Transgenic for the Thymidine Kinase Gene Driven by the alpha IIb Promoter Blood, September 15, 1998; 92(6): 2012 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sogo, M. Inaba, H. Ogata, H. Hisha, Y. Adachi, S.-i. Mori, J. Toki, K. Yamanishi, H. Kanzaki, M. Adachi, et al. Induction of c-kit Molecules on Human CD34+/c-kit Stem Cells, November 1, 1997; 15(6): 420 - 429. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Lian, J. Toki, C. Yu, H. Hayashi, R. Yasumizu, K. Sugiura, T. Jin, M. Inaba, H. Hisha, Y. Li, et al. Intrathymically Injected Hemopoietic Stem Cells Can Differentiate into All Lineage Cells in the Thymus: Differences Between c-kit+ Cells and c-kit Stem Cells, November 1, 1997; 15(6): 430 - 436. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Doi, M. Inaba, Y. Yamamoto, S. Taketani, S.-I. Mori, A. Sugihara, H. Ogata, J. Toki, H. Hisha, K. Inaba, et al. Pluripotent hemopoietic stem cells are c-kit PNAS, March 18, 1997; 94(6): 2513 - 2517. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
